Study unveils new molecular switch protecting cells from death

Researchers at LMU University Hospital have discovered a new molecular switch that protects against cell death.

Programmed cell death protects the body against cancer and other diseases. A team of researchers led by Professor Alexander Bartelt from the Institute for Cardiovascular Prevention (IPEK) has decoded a new mechanism by which oxidative stress influences cell death. The researchers hope this discovery will lead to novel approaches for targeting cancer cells and other diseases. Their findings were recently published in the journal Cell Death & Differentiation.

When the lipids in the plasma are attacked, it is referred to as ferroptosis. In a chain reaction, the lipid molecules that make up the membrane are being destroyed and the cell literally dissolves.

Ferroptosis is a recently discovered form of cell death and we're searching for ways to control the process."

Alexander Bartelt, Professor, Institute for Cardiovascular Prevention

The team concentrated on the proteasome, which functions as a sort of recycling bin for the cell. Through the operations of the proteasome, old or damaged proteins are broken down and made available to the cell again.

Using state-of-the-art methods of mass spectrometry, the team investigated whether the recycling of proteins is disrupted during ferroptosis. In this way, the researchers found that the proteasome is effectively clogged up, accelerating cell death. At the same time, they identified the enzyme DDI2, which cranks up the recycling again and protects against cell death. "DDI2 is a protease - a type of enzyme it's possible to therapeutically influence," says Anahita Ofoghi, who carried out the study.

The findings point to a new way of manipulating cell death. This could be relevant not only for new cancer therapies, but also indicates how we might be able to protect healthy cells against death. "We've contributed a small piece to the fascinating puzzle of ferroptosis," says Bartelt. The authors now hope to exploit this molecular mechanism for therapies.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MaxCyte celebrates 25 years of innovation driving cell engineering-based therapeutics